Brief: 4D Molecular Therapeutics Announces Updates On Clinical Pipeline And Additional Preclinical Programs

4D Molecular Therapeutics

09/01/2023 14:06

4D Molecular Therapeutics Inc  FDMT.O :
    * 4D MOLECULAR THERAPEUTICS ANNOUNCES UPDATES ON CLINICAL
PIPELINE
AND ADDITIONAL PRECLINICAL PROGRAMS
    * 4D MOLECULAR THERAPEUTICS - FULL CLINICAL DATA FROM PHASE
1/2
FABRY DISEASE CARDIOMYOPATHY TRIALS TO BE REPORTED AT
WORLDSYMPOSIUM IN FEBRUARY 2023
    * 4D MOLECULAR THERAPEUTICS INC - AS OF JANUARY 2023, NO
ADDITIONAL PATIENTS WILL BE ENROLLED ON CURRENT FABRY DISEASE
CLINICAL TRIALS

Source text for Eikon:  ID:nGNXc3KQFs 
Further company coverage:  FDMT.O